Bausch+Lomb to acquire Ista Pharmaceuticals
Bausch+Lomb has unveiled a $500 million deal to acquire Ista Pharmaceuticals Inc., a maker of branded prescription drugs for eye care. Bausch+Lomb said Monday that the transaction, which has been unanimously approved by the boards of both companies, is slated to close in the second quarter.